ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

OPTN OptiNose Inc

0.8776
0.00 (0.00%)
03 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
OptiNose Inc OPTN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 0.8776 09:00:00
개장가 저가 고가 종가 전일 종가
0.8776
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
25/04/202420:00GLOBEOptinose Provides Corporate Update on XHANCE Launch and..
05/04/202405:01GLOBEOptinose to Present at the Needham Virtual Healthcare..
16/03/202404:34GLOBEXHANCE Approved by FDA as First and Only Medication..
09/03/202406:10EDGAR2Form 8-K - Current report
08/03/202406:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/03/202421:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/03/202421:00GLOBEOptinose Reports Fourth Quarter and Full Year 2023 Financial..
07/03/202421:00EDGAR2Form 8-K - Current report
01/03/202406:40GLOBEOptinose Announces Reporting Date for Fourth Quarter 2023..
01/03/202406:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/03/202406:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/02/202421:08EDGAR2Form 8-K - Current report
23/02/202406:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
15/02/202410:48EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/02/202407:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
02/02/202404:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/01/202406:05EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
19/01/202402:00GLOBEOptinose Announces the Publication of ReOpen Phase 3..
22/12/202306:11EDGAR2Form 8-K - Current report
21/12/202302:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202302:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202322:48DJNOptinose Shares Slide Premarket as FDA Extends Xhance Review
06/12/202321:02EDGAR2Form 8-K - Current report
06/12/202321:00GLOBEOptinose Announces 3-Month Extension of FDA Review Period..
22/11/202323:00GLOBEOptinose to Present at the 35th Annual Piper Sandler..
09/11/202321:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202321:02EDGAR2Form 8-K - Current report
09/11/202321:00GLOBEOptinose Reports Third Quarter 2023 Financial Results and..
27/10/202321:00GLOBEOptinose Announces Reporting Date for Third Quarter 2023..
22/09/202322:01GLOBEOptinose to Present at the 2023 Cantor Global Healthcare..
20/09/202308:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/09/202308:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/08/202313:15EDGAR2Form EFFECT - Notice of Effectiveness
11/08/202305:05EDGAR2Form S-3 - Registration statement under Securities Act of..
10/08/202320:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/08/202320:02EDGAR2Form 8-K - Current report
10/08/202320:00GLOBEOptinose Reports Second Quarter 2023 Financial Results and..
27/07/202320:27EDGAR2Form 8-K - Current report
27/07/202320:00GLOBEOptinose Announces Preliminary Second Quarter 2023 XHANCE..
17/06/202305:08GLOBEOptinose Announces Inducement Grant Under Nasdaq Listing..
03/06/202302:00GLOBEOptinose to Present at the Jefferies Healthcare Conference
11/05/202320:00GLOBEOptinose Reports First Quarter 2023 Financial Results and..
04/05/202320:00GLOBEOptinose Announces FDA Acceptance of Supplemental New Drug..

최근 히스토리

Delayed Upgrade Clock